Biomex
Private Company
Total funding raised: $9.8M
Overview
BIOMEX is a well-established, private German company that has positioned itself as a critical infrastructure provider in the life sciences and diagnostics sectors. Its core business revolves around a massive biobank and sample procurement network, supplying high-quality human raw materials (blood, tissue, cells) and supporting services from basic research through to IVD regulatory approval. The company leverages strategic donation centers in Germany and Cameroon, a vast partner network, and in-house laboratory capabilities to offer reliability, speed, and compliance, particularly under the stringent EU IVDR. Its model is built on enabling client R&D by removing bottlenecks in sample sourcing and testing.
Technology Platform
Integrated biospecimen ecosystem comprising a massive biobank (Sampleshop), a global procurement network (own donation centers & partner clinics), in-house processing/analytical laboratories, and a dedicated IVD CRO framework for regulatory performance evaluations.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
BIOMEX competes in a fragmented global market for biospecimens and research services against large commercial biobanks (e.g., Discovery Life Sciences, BioIVT), diagnostic CROs, and academic tissue banks. Its key differentiators are the scale of its immediately available inventory in Europe, its integrated IVD CRO, and its strategic donor centers providing geographic diversity.